Histopathologic studies in renal transplant recipient dogs receiving treatment with FK-506.
D000284:Administration, Oral; D000818:Animals; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D005260:Female; D006084:Graft Rejection; D006321:Heart / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity*; D007273:Injections, Intramuscular; D007422:Intestines / Q000187:drug effects / Q000473:pathology; D007668:Kidney / Q000187:drug effects; D016030:Kidney Transplantation; D008099:Liver / Q000187:drug effects / Q000473:pathology; D009206:Myocardium / Q000473:pathology; D011183:Postoperative Complications / Q000175:diagnosis / Q000473:pathology; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D016559:Tacrolimus; D014657:Vasculitis / Q000139:chemically induced / Q000473:pathology
D007166:Immunosuppressive Agents; D011725:Pyridines; D016559:Tacrolimus